GLP-1 drugs may boost male fertility markers
19/06/2026
Clinical Takeaway: GLP-1 receptor agonists don’t appear to acutely suppress the male hypothalamic-pituitary-gonadal axis and may improve testosterone and some
Clinical Takeaway: GLP-1 receptor agonists don’t appear to acutely suppress the male hypothalamic-pituitary-gonadal axis and may improve testosterone and some
The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or
CHICAGO — A multidisciplinary group of menopause experts developed new comorbidity-specific guidance on non-hormone therapy for moderate-to-severe vasomotor symptoms. First-Line
Brain Tumor Report Brain tumors diagnosed in 11 nurses at Newton-Wellesley Hospital in suburban Boston were not caused by any
Introducción Fixed-duration therapy with pirtobrutinib (Jaypirca) plus venetoclax (Venclexta) and rituximab improved progression-free survival (PFS) in patients with relapsed/refractory chronic